Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04189770 · ClinicalTrials.gov registry record
Lifestyle Behavior Influences Among African American Patients With Stage 0-III Prostate Cancer Survivors and Their Partners
A clinical trial of Stage III Prostate Cancer AJCC v8 and Cancer Survivor, sponsored by M.D. Anderson Cancer Center.
- Active
- Registry status
- 200
- Enrollment target
- 1
- Study location
NCT04189770 is a study of Stage III Prostate Cancer AJCC v8 and Cancer Survivor that is active but no longer recruiting, run by M.D. Anderson Cancer Center. The registered enrollment target is 200 participants, below the 242-participant average among 28 other Stage III Prostate Cancer AJCC v8 trials with a reported enrollment target (17% lower). The trial reports 1 study location across 1 state.
The verdict
NCT04189770, a study of Stage III Prostate Cancer AJCC v8 and Cancer Survivor, is active but no longer recruiting, sponsored by M.D. Anderson Cancer Center.
- ACTIVE NOT RECRUITING
- Registry status
- 200 participants
- Enrollment target
- 1
- Study location
Study Summary
This trial studies the day-to-day stress, social support, and health lifestyle behaviors (such as physical activity and nutrition) in African American patients with stage 0-III prostate cancer survivors and their partners. How patients cope with stress may affect their lifestyle behaviors. This study may help understand not only survivors' behaviors but also partners' behaviors and how they interact.
Conditions Studied
Interventions
- OTHER Survey Administration
- OTHER Questionnaire Administration
- DEVICE Accelerometer
- OTHER Ecological Momentary Assessment
Study Locations (1)
Texas
- M D Anderson Cancer Center - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2020-02-26 |
| Est. Completion | 2026-02-28 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04189770
The ClinicalTrials.gov registry entry for NCT04189770 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 200 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 242-participant average among 28 other Stage III Prostate Cancer AJCC v8 trials with a reported enrollment target (17% lower). The listed sponsor is M.D. Anderson Cancer Center, which has 2,692 total studies on file at ClinicalTrials.gov.
The record links to 10 conditions, with Stage III Prostate Cancer AJCC v8 appearing as the primary indexed condition, and to 4 interventions - of which Survey Administration is the first listed.
NCT04189770 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.
Frequently Asked Questions
What is clinical trial NCT04189770 about?
NCT04189770 is a clinical study titled "Lifestyle Behavior Influences Among African American Patients With Stage 0-III Prostate Cancer Survivors and Their Partners". This trial studies the day-to-day stress, social support, and health lifestyle behaviors (such as physical activity and nutrition) in African American patients with stage 0-III prostate cancer survivors and their partners. How patients cope with stress may affect their lifestyle behaviors. This stud...
What is the current status of trial NCT04189770?
This trial is currently active not recruiting. The enrollment target is 200 participants. The study started on 2020-02-26. Estimated completion is 2026-02-28.
What conditions does trial NCT04189770 study?
This clinical trial studies the following conditions: Stage III Prostate Cancer AJCC v8, Cancer Survivor, Stage II Prostate Cancer AJCC v8, Stage I Prostate Cancer AJCC v8, Stage IIC Prostate Cancer AJCC v8.
What interventions are being tested in trial NCT04189770?
The interventions under investigation include: Survey Administration (OTHER), Questionnaire Administration (OTHER), Accelerometer (DEVICE), Ecological Momentary Assessment (OTHER).
Who is sponsoring clinical trial NCT04189770?
This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04189770 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Stage III Prostate Cancer AJCC v8
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
SBRT Versus Hypofractionated Radiotherapy for Biochemically Recurrent or Oligometastatic Prostate Adenocarcinoma
RECRUITING · Phase 3
-
Golf Recreational Exercise for Enhanced Survivorship in Prostate Cancer Survivors
RECRUITING · NA
-
High Dose-Rate Brachytherapy and Stereotactic Body Radiotherapy for the Treatment of Prostate Adenocarcinoma
RECRUITING · NA
-
Abiraterone and Prednisone or Darolutamide for the Treatment of Advanced Prostate Cancer
RECRUITING · Phase 2
-
Evaluating In Home Cancer Therapy Versus In Clinic Cancer Therapy in Black Men With Locally Advanced, Biochemically Recurrent and Metastatic Prostate Cancer
RECRUITING · Phase 2
-
Accuracy of 18F-rhPSMA-7.3 PET/ MRI for Prediction of Lymph Node Metastasis in Localized High-Risk Prostate Cancer
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.